Markets by TradingView

Bayer shares plunge after blood-thinning drug trial halted

Posted
Via The Financial Times
German group says prospective blockbuster asundexian failed to demonstrate efficacy

Continue reading at The Financial Times »

Other items that may interest you

Place block trades quickly and at optimal prices with Bitstamp OTC RFQ

Bitstamp Monthly Briefing – October 2023

Bitstamp Earn Lending: October 2023 Performance Report released

End 2023 on a crypto lending high - With APY rising up to 8%

© Copyright 2023 Asset Management Star
Powered by Creative Circle Media Solutions